Vital Signs - Injectable Drug Delivery: Easing the Pain with Technology


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This issue of Vital Signs, released on September 12, 2011, provides a strategic insight on injectable drug delivery market.Additionally, a company spotlight is provided for Unilife Medical Solutions, a U.S. based medical device company specializing in the design and development of innovative and safe drug and vaccine injection systems. Reimbursement and regulatory news from the FDA is also provided for week of Aug 29, 2011.

Table of Contents

Vital Signs - Injectable Drug Delivery: Easing the Pain with TechnologyVital Signs: 12 September 2011This week's issue

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.